PKM and cancer: LINC01554 promotes proteasomal degradation of PKM2, an important enzyme at the late stage of glycolysis, and inhibits the Akt/mTOR signaling pathway, one of the key signalling pathways that mediates cellular biosynthesis and aerobic glycolysis in cancer cells.